According to Bloomberg, China is considering waiving up to 125% retaliatory tariffs on certain U.S. imports—including medical equipment, ethane, and aircraft leasing—as economic pressure from the prolonged trade conflict with Washington mounts.
This potential move mirrors previous U.S. actions, such as exempting electronics from a 145% tariff list on Chinese imports to reduce domestic costs.
Key insights:
-
Discussions are still at an early stage, with no final decisions confirmed.
-
The proposed exemptions highlight China’s continued reliance on U.S. products in critical healthcare and industrial sectors.
-
Meanwhile, Apple is reportedly accelerating its supply chain shift, aiming to produce all U.S.-bound iPhones in India, a sign of the broader reconfiguration of global manufacturing strategies.
Despite escalating rhetoric, both sides appear to be adjusting policies in recognition of mutual economic interdependence, showing that strategic flexibility may still exist beneath the surface of hardline stances.